• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼患者眼表疾病管理:对加拿大青光眼专家的调查。

Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists.

机构信息

Division of Ophthalmology, Department of Surgery, University of Calgary, Calgary, AB.

Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal (CHUM).

出版信息

J Glaucoma. 2020 Dec;29(12):1162-1172. doi: 10.1097/IJG.0000000000001659.

DOI:10.1097/IJG.0000000000001659
PMID:33264166
Abstract

UNLABELLED

PRéCIS:: Ocular surface disease (OSD) in glaucoma is an area for improvement in the management of patients with glaucoma. This study explores the knowledge of glaucoma subspecialists toward OSD in glaucoma, then provides a suggested treatment algorithm.

PURPOSE

To assess the attitudes, knowledge, and level of comfort of Canadian glaucoma specialists with respect to the assessment and management of OSD among patients with glaucoma.

METHODS

Ophthalmologist members of the Canadian Glaucoma Society with fellowship training in glaucoma were contacted to participate in this cross-sectional survey study. Responses were recorded to statements regarding attitudes toward OSD in glaucoma, and assessment and management modalities. These were recorded primarily in the form of a Likert scale rated 1 to 7 from "strongly disagree" to "strongly agree." Descriptive statistics were generated, and mean and SD for responses on Likert scales.

RESULTS

Thirty-six responses were included. All respondents agreed that comprehensive management of OSD could improve quality of life, 97% agreed it could lead to better glaucoma outcomes, whereas only 22% agreed it is presently being adequately managed in glaucoma practices. Respondents were asked to list all treatment modalities they felt knowledgeable about, ranging from 100% for optimizing topical glaucoma therapies to 31% for serum tears. Nearly all respondents (92%) agreed that a suggested algorithm for the treatment of OSD in glaucoma could improve their approach to management.

CONCLUSION

OSD is a common comorbidity of glaucoma. Although respondents overwhelmingly agreed that comprehensive management of OSD may lead to improved quality of life and glaucoma-related outcomes, only a small percentage felt it was presently adequately managed. Increasing knowledge related to the assessment and management of OSD in glaucoma may in the future improve patient care.

摘要

目的

评估加拿大青光眼专家对青光眼患者眼表疾病(OSD)评估和管理的态度、知识和舒适度。

方法

联系了具有青光眼专科培训 fellowship的加拿大青光眼学会眼科医生会员参与这项横断面调查研究。记录了他们对青光眼患者眼表疾病态度、评估和管理模式的评估的回应。这些回应主要以 1 到 7 的李克特量表形式记录,从“强烈不同意”到“强烈同意”。生成了描述性统计数据,并对李克特量表上的响应进行了均值和标准差计算。

结论

OSD 是青光眼的常见合并症。尽管大多数受访者一致认为全面管理 OSD 可能会改善生活质量和青光眼相关结果,但只有一小部分人认为目前在青光眼实践中得到了充分的管理。增加对青光眼患者 OSD 评估和管理的相关知识,可能会在未来改善患者的护理。

相似文献

1
Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists.青光眼患者眼表疾病管理:对加拿大青光眼专家的调查。
J Glaucoma. 2020 Dec;29(12):1162-1172. doi: 10.1097/IJG.0000000000001659.
2
New strategies for the management of ocular surface disease in glaucoma patients.青光眼患者眼表疾病管理的新策略。
Curr Opin Ophthalmol. 2021 Mar 1;32(2):134-140. doi: 10.1097/ICU.0000000000000739.
3
Prevalence of Ocular Surface Disease and Associated Risk Factors in Glaucoma Patients: A Survey Study of Ophthalmologists.青光眼患者的眼表疾病患病率及相关危险因素:眼科医生的调查研究。
Turk J Ophthalmol. 2022 Oct 28;52(5):302-308. doi: 10.4274/tjo.galenos.2021.20726.
4
Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.青光眼患者的眼表疾病:联合用药及防腐剂的影响
Optom Vis Sci. 2015 Sep;92(9):e222-6. doi: 10.1097/OPX.0000000000000542.
5
Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease.一项临床审计,考察不含苯扎氯铵的抗青光眼药物对有眼表疾病症状患者的影响。
Clin Exp Ophthalmol. 2015 Apr;43(3):214-20. doi: 10.1111/ceo.12431. Epub 2014 Oct 2.
6
A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface (.).一项关于青光眼专家对眼表术前(小梁切除术)管理的全国性调查(.)
Semin Ophthalmol. 2016;31(6):519-25. doi: 10.3109/08820538.2014.986585. Epub 2014 Dec 9.
7
Ocular surface disease exacerbated glaucoma: optimizing the ocular surface improves intraocular pressure control.眼表疾病加重青光眼:改善眼表可优化眼压控制。
J Glaucoma. 2014 Jan;23(1):56-60. doi: 10.1097/IJG.0b013e318264cd68.
8
Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.局部青光眼治疗与眼表疾病:一项前瞻性对照队列研究。
Can J Ophthalmol. 2015 Apr;50(2):132-6. doi: 10.1016/j.jcjo.2014.11.006.
9
Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases.治疗不耐受局部治疗的青光眼患者的眼表疾病对眼内压的影响:10 例报告。
J Glaucoma. 2018 Dec;27(12):1105-1111. doi: 10.1097/IJG.0000000000001041.
10
Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis.青光眼患者的眼表疾病评估:临床参数、自我报告评估和角膜地形图分析。
J Glaucoma. 2018 Sep;27(9):794-801. doi: 10.1097/IJG.0000000000001007.

引用本文的文献

1
Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy.眼表疾病:局部青光眼治疗一种已知但被忽视的副作用。
Front Toxicol. 2023 Jul 21;5:1067942. doi: 10.3389/ftox.2023.1067942. eCollection 2023.
2
Prevalence of Ocular Surface Disease and Associated Risk Factors in Glaucoma Patients: A Survey Study of Ophthalmologists.青光眼患者的眼表疾病患病率及相关危险因素:眼科医生的调查研究。
Turk J Ophthalmol. 2022 Oct 28;52(5):302-308. doi: 10.4274/tjo.galenos.2021.20726.